arterolane

 

Topic mentions per year

Topic mentions per year

2005-2018
02420052018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
We describe the first systematic study of antimalarial 1,2,4-trioxolanes bearing a substitution pattern regioisomeric to that of… (More)
Is this relevant?
2015
2015
Antimalarial agents artemisinin and arterolane act via initial reduction of a peroxide bond in a process likely mediated by… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2014
2014
Arterolane (RBx11160, OZ277) maleate is a rapidly acting synthetic trioxolane anti-malarial. This randomized, placebo controlled… (More)
Is this relevant?
Review
2014
Review
2014
Malaria has been very prevalent vector-borne disease in India and until date bears enormous implications on health care services… (More)
  • figure 1
  • figure 2
Is this relevant?
2014
2014
Novel synthetic endoperoxides are being evaluated as new components of artemisinin combination therapies (ACTs) to treat… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 2
Is this relevant?
2011
2011
Arterolane (RBx 11160) maleate is a novel, rapidly acting synthetic trioxolane antimalarial compound being developed by Ranbaxy… (More)
Is this relevant?
2010
2010
The structure and stereochemistry of the cyclohexane substituents of analogues of arterolane (OZ277) had little effect on potency… (More)
  • table 1
  • table 2
  • table 3
  • table 5
  • table 4
Is this relevant?
2010
2010
Peroxidic antimalarials such as the semisynthetic artemisinins are critically important in the treatment of drug-resistant… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
  • figure 3
Is this relevant?
2010
2010
BACKGROUND Drug-resistant Plasmodium falciparum malaria necessitates development of novel drugs for treatment.The present study… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2010
2010
OBJECTIVE Arterolane maleate is an antimalarial drug currently under Phase III clinical evaluation, and presents a simple… (More)
Is this relevant?